Li, X, Lu, Z, Zhang, J, Zhang, X, Zhang, S, Zhou, J et al.. The urgent need to empower rare disease organizations in China: an interview-based study. Orphanet J Rare Dis. 2020;15 (1):282. doi: 10.1186/s13023-020-01568-5. PubMed PMID:33046132 PubMed Central PMC7552513.
Malinowski, KP, Kawalec, P, Trąbka, W, Sowada, C, Petrova, G, Manova, M et al.. Health technology assessment and reimbursement policy for oncology orphan drugs in Central and Eastern Europe. Orphanet J Rare Dis. 2020;15 (1):277. doi: 10.1186/s13023-020-01556-9. PubMed PMID:33032634 PubMed Central PMC7545889.
Chua, KP, Conti, RM. Trends In Orphan Drug Spending And Out-Of-Pocket Spending Among US Children, 2013-18. Health Aff (Millwood). 2020;39 (10):1806-1811. doi: 10.1377/hlthaff.2020.00595. PubMed PMID:33017253 .
Balijepalli, C, Gullapalli, L, Druyts, E, Yan, K, Desai, K, Barakat, S et al.. Can Standard Health Technology Assessment Approaches Help Guide the Price of Orphan Drugs in Canada? A Review of Submissions to the Canadian Agency for Drugs and Technologies in Health Common Drug Review. Clinicoecon Outcomes Res. 2020;12 :445-457. doi: 10.2147/CEOR.S264589. PubMed PMID:32922050 PubMed Central PMC7455764.
Hollak, CEM, Sirrs, S, van den Berg, S, van der Wel, V, Langeveld, M, Dekker, H et al.. Registries for orphan drugs: generating evidence or marketing tools?. Orphanet J Rare Dis. 2020;15 (1):235. doi: 10.1186/s13023-020-01519-0. PubMed PMID:32883346 PubMed Central PMC7469301.
Miller, KL, Mueller, C, Liu, G, Miller Needleman, KI, Maynard, J. FDA orphan products clinical trial grants: assessment of outcomes and impact on rare disease product development. Orphanet J Rare Dis. 2020;15 (1):234. doi: 10.1186/s13023-020-01514-5. PubMed PMID:32883327 PubMed Central PMC7469294.
Badia, X, Vico, T, Shepherd, J, Gil, A, Poveda-Andrés, JL, Hernández, C et al.. Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019. Orphanet J Rare Dis. 2020;15 (1):224. doi: 10.1186/s13023-020-01507-4. PubMed PMID:32859228 PubMed Central PMC7456380.
Coyle, D, Durand-Zaleski, I, Farrington, J, Garrison, L, Graf von der Schulenburg, JM, Greiner, W et al.. HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies. Eur J Health Econ. 2020; :. doi: 10.1007/s10198-020-01212-w. PubMed PMID:32794011 .
Toumi, M, Millier, A, Cristeau, O, Thokagevistk-Desroziers, K, Dorey, J, Aballéa, S et al.. Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population. Front Med (Lausanne). 2020;7 :323. doi: 10.3389/fmed.2020.00323. PubMed PMID:32766260 PubMed Central PMC7379418.
Bannenberg, WJ, 't Hoen, EFM. [Orphan drugs and drug pirates]. Ned Tijdschr Geneeskd. 2020;164 :. . PubMed PMID:32749801 .
Marselis, D, Hordijk, L. From blockbuster to "nichebuster": how a flawed legislation helped create a new profit model for the drug industry. BMJ. 2020;370 :m2983. doi: 10.1136/bmj.m2983. PubMed PMID:32727745 .
Burns, TM, Crowell, JL, Smith, AG. A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians, and society, part 2. Muscle Nerve. 2020; :. doi: 10.1002/mus.27018. PubMed PMID:32725709 .
Burns, TM, Crowell, JL, Smith, AG. A crisis in US drug pricing: Consequences for patients with neuromuscular diseases, physicians and society, part 1. Muscle Nerve. 2020; :. doi: 10.1002/mus.27015. PubMed PMID:32725634 .
Mullin, AP, Corey, D, Turner, EC, Liwski, R, Olson, D, Burton, J et al.. Standardized Data Structures in Rare Diseases: CDISC User Guides for Duchenne Muscular Dystrophy and Huntington's Disease. Clin Transl Sci. 2020; :. doi: 10.1111/cts.12845. PubMed PMID:32702147 .
Bayoumy, AB, de Boer, NKH, Ansari, AR, Crouwel, F, Mulder, CJJ. Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective. J Pharm Policy Pract. 2020;13 :45. doi: 10.1186/s40545-020-00249-9. PubMed PMID:32695427 PubMed Central PMC7366879.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.